Immune Cell Therapy

ICT is developing a personalized vaccine treatment to help cancer from recurring. A small amount of the patient's own primary tumor is used to prepare the vaccine, so that the vaccine targets the specific cancer that the patient has. This personalized vaccine is much simpler and cheaper to produce than existing cancer vaccine therapies that are being tested. ICT has received approval from the FDA for its IND to begin clinical trials for lung cancer, which will initially be conducted at the Unive...Show all

ICT is developing a personalized vaccine treatment to help cancer from recurring. A small amount of the patient's own primary tumor is used to prepare the vaccine, so that the vaccine targets the specific cancer that the patient has. This personalize...Show all

Company (Alive / Active)

All investors data 1 Investors

• Capital Midwest Fund